ProtoneogracillinCAS# 191334-50-6 |
Quality Control & MSDS
Number of papers citing our products
Chemical structure
Cas No. | 191334-50-6 | SDF | Download SDF |
PubChem ID | N/A | Appearance | Powder |
Formula | C51H84O23 | M.Wt | 1065.2 |
Type of Compound | Steroid Saponins and its Sapogenins | Storage | Desiccate at -20°C |
Solubility | Soluble in Chloroform,Dichloromethane,Ethyl Acetate,DMSO,Acetone,etc. | ||
General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. |
Protoneogracillin Dilution Calculator
Protoneogracillin Molarity Calculator
1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
1 mM | 0.9388 mL | 4.694 mL | 9.3879 mL | 18.7758 mL | 23.4698 mL |
5 mM | 0.1878 mL | 0.9388 mL | 1.8776 mL | 3.7552 mL | 4.694 mL |
10 mM | 0.0939 mL | 0.4694 mL | 0.9388 mL | 1.8776 mL | 2.347 mL |
50 mM | 0.0188 mL | 0.0939 mL | 0.1878 mL | 0.3755 mL | 0.4694 mL |
100 mM | 0.0094 mL | 0.0469 mL | 0.0939 mL | 0.1878 mL | 0.2347 mL |
* Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. |
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
- 2,4,6-trichlorol-3-methyl-5-methoxyphenol-1-O-β-D-glucopyranosyl-(1→6)-β-D-glucopyranoside
Catalog No.:BCX1642
CAS No.:1447969-66-5
- (2,4,6-trichloro-3-hydroxy-5-methoxyphenyl)methyl β-D-glucopyranoside
Catalog No.:BCX1641
CAS No.:2839363-14-1
- 4-chloro-3-methoxy-5-methylphenyl 6-O-(6-deoxy-β-L-mannopyranosyl)-β-D-glucopyranoside
Catalog No.:BCX1640
CAS No.:2839363-15-2
- (2,4-dichloro-3,5-dimethoxyphenyl)methyl 6-O-β-D-glucopyranosyl-β-D-glucopyranoside
Catalog No.:BCX1639
CAS No.:2739844-79-0
- 1,3-Dilinoleoyl-2-oleoylglycerol
Catalog No.:BCX1638
CAS No.:2190-22-9
- 10-O-[(E)-3,4-Dimethoxycinnamoyl]-catalpol
Catalog No.:BCX1637
CAS No.:834155-36-1
- 10-O-trans-p-methoxycinnamoyl-catalpol
Catalog No.:BCX1636
CAS No.:201605-27-8
- BioCrick001
Catalog No.:BCX1635
CAS No.:2600799-45-7
- Epiberberine chloride
Catalog No.:BCX1634
CAS No.:889665-86-5
- (7aR,8R,13aR,13bS,13cR)-Dodecahydro-8-hydroxy-1H,5H,10H-dipyrido[2,1-f:3',2',1'-ij][1,6]naphthyridin...
Catalog No.:BCX1633
CAS No.:2306139-04-6
- 2-[3-(3,7-Dimethyl-2,6-octadien-1-yl)-2,4-dihydroxyphenyl]-5,7-dihydroxy-4H-1-benzopyran-4-one
Catalog No.:BCX1632
CAS No.:2226467-12-3
- 12β-Acetoxyganoderic Acid θ
Catalog No.:BCX1631
CAS No.:2374206-90-1
- Camellianin B
Catalog No.:BCX1644
CAS No.:109232-76-0
- n-Octadecane
Catalog No.:BCX1645
CAS No.:593-45-3
- Tellimagrandin II
Catalog No.:BCX1646
CAS No.:81571-72-4
- Norswertianin
Catalog No.:BCX1647
CAS No.:22172-15-2
- Wilfordinine D
Catalog No.:BCX1648
CAS No.:256937-98-1
- 1-Methyl-2-[(4Z,7Z)-4,7-tridecadienyl]-4(1H)-quinolone
Catalog No.:BCX1649
CAS No.:120693-53-0
- 1-Methyl-2-[(6Z,9Z)-6,9-pentadecadiene]-4(1H)-quinolone
Catalog No.:BCX1650
CAS No.:120693-52-9
- β-D-glucopyranosyl 3-O-[(O-β-D-xylopyranosyl-(1→2) (O-α-L-rhamnopyranosyl(1→3)β-D-glucuronopyranosyl...
Catalog No.:BCX1651
CAS No.:111567-21-6
- Erythrosin B
Catalog No.:BCX1652
CAS No.:568-63-8
- Entadamide A 2' -O- ( 6''-O-β-D-glucopyranosyl ) -β-D-glucopyranoside
Catalog No.:BCX1653
CAS No.:1427191-48-7
- Tetrahydrojatrorrhizine
Catalog No.:BCX1654
CAS No.:27313-86-6
- (-)-(E)-a-Atlantone
Catalog No.:BCX1655
CAS No.:108645-54-1
Characterization of the cholesterol biosynthetic pathway in Dioscorea transversa.[Pubmed:37142228]
J Biol Chem. 2023 Jun;299(6):104768.
Cholesterol is the precursor of bioactive plant metabolites such as steroidal saponins. An Australian plant, Dioscorea transversa, produces only two steroidal saponins: 1beta-hydroxyProtoneogracillin and Protoneogracillin. Here, we used D. transversa as a model in which to elucidate the biosynthetic pathway to cholesterol, a precursor to these compounds. Preliminary transcriptomes of D. transversa rhizome and leaves were constructed, annotated, and analyzed. We identified a novel sterol side-chain reductase as a key initiator of cholesterol biosynthesis in this plant. By complementation in yeast, we determine that this sterol side-chain reductase reduces Delta(24,28) double bonds required for phytosterol biogenesis as well as Delta(24,25) double bonds. The latter function is believed to initiate cholesterogenesis by reducing cycloartenol to cycloartanol. Through heterologous expression, purification, and enzymatic reconstitution, we also demonstrate that the D. transversa sterol demethylase (CYP51) effectively demethylates obtusifoliol, an intermediate of phytosterol biosynthesis and 4-desmethyl-24,25-dihydrolanosterol, a postulated downstream intermediate of cholesterol biosynthesis. In summary, we investigated specific steps of the cholesterol biosynthetic pathway, providing further insight into the downstream production of bioactive steroidal saponin metabolites.
The cytotoxicity of methyl protoneogracillin (NSC-698793) and gracillin (NSC-698787), two steroidal saponins from the rhizomes of Dioscorea collettii var. hypoglauca, against human cancer cells in vitro.[Pubmed:12820229]
Phytother Res. 2003 Jun;17(6):620-6.
In our continuous studies of anticancer activity of steroidal saponins from the rhizomes of Dioscorea collettii var. hypoglauca (Dioscoreaceae), methyl Protoneogracillin (NSC-698793) and gracillin (NSC-698787) were tested for cytotoxicity against human cancer cell lines from leukemia and eight solid tumor diseases. As a result, methyl Protoneogracillin was cytotoxic against all the test cell lines with GI(50) < 100 micro M, especially selectively against two leukemia lines (CCRF-CEM and RPMT-8226), one colon cancer line (KM12), two central nervous system (CNS) cancer lines (SF-539 and U251), one melanoma line (M14), one renal cancer line (786-0), one prostate cancer line (DU-145), and one breast cancer line (MDA-MB-435), with GI(50) < or = 2.0 micro M. Leukemia, CNS cancer, and prostate cancer were the most sensitive subpanels, while ovarian cancer was the least sensitive subpanels. The preliminary toxicity studies showed that the maximum tolerant dose was 600 mg/kg for methyl Protoneogracillin to mice. Gracillin was cytotoxic against most cell lines with GI(50), TGI and LC(50) at micromolar levels, but no activity against EKVX (non-small cell lung cancer), HT29 (colon cancer), OVCAR-5 (ovarian cancer), and SN12C (renal cancer). Based on structure-activity relationship, C-25 R/S con fi guration was critical for leukemia selectivity between methyl Protoneogracillin and methyl protogracillin. F-ring was critical to selectivity between furostanol (methyl Protoneogracillin and methyl protogracillin) and spirostanol (gracillin) saponins in this study. By an analysis of COMPARE software, no compounds in the NCI's database had similar mean graphs to those of methyl Protoneogracillin and gracillin, respectively, indicating potential novel mechanism(s) of action involved. Put all in together, methyl Protoneogracillin has been selected as a potential anticancer candidate for hollow fi ber assay to nude mice, but gracillin will not be pursued due to lack of selectivity against human cancer diseases.
Antineoplastic agents. II. Four furostanol glycosides from rhizomes of Dioscorea collettii var. hypoglauca.[Pubmed:17252340]
Planta Med. 1997 Apr;63(2):161-5.
During activity-guided fractionations to screen for antineoplastic agents, further studies by means of preparative HPLC led to the isolation of four known furostanol saponins: protoneodioscin, protodioscin, Protoneogracillin, protogracillin, along with their corresponding artifacts: methyl protoneodioscin, methyl protodioscin, methyl Protoneogracillin, and methyl protogracillin, from the rhizomes of Dioscorea collettii var. hypoglauca. Among them, protoneodioscin, protodioscin, and Protoneogracillin are first reported from the title plant. The structures of the compounds were established on the basis of chemical evidence and spectral analysis (1H-NMR, 13C-IMMR, 1H-1H COSY, HMQC, HMBC, and FAB-MS). These eight compounds all caused morphological abnormality of Pyricularia oryzae mycelia. They also showed cytotoxic activities against the cancer cell line of K562 in vitro as antineoplastic agents.